stockrowEnvista Holdings Corporation
NVST Healthcare Medical Instruments & Supplies
Envista Holdings Corporation’s revenue for fiscal 2025 (year ended December 2025) was $2.7 billion, up 8.32% from fiscal 2024.
- Revenue
- +3.22%
- EPS
- +1,855.6%
- Free cash flow
- −6.48%
- Total debt
- −1.13%
Quarter to September 2026, against a year earlier
Follow NVST
Alert me
Envista Holdings Corporation (NVST) Return on equity
Envista Holdings Corporation's return on equity over the twelve months to 30 September 2026 was 20.5%, up 19.0 percentage points from fiscal 2025 (1.56%). Over the past ten years it has ranged from −31.5% (fiscal 2024) to 8.75% (fiscal 2021); the current reading is higher than 50% of that period. That is above the Medical Instruments & Supplies industry median of 0.00% and above the Healthcare sector median of −26.3%.
Return on equity, annual
Embed this chart
Annual newest first
| Period | Return on equity | Change (points) |
|---|---|---|
| FY2025 | 1.56% | 33.03 |
| FY2024 | −31.5% | (29.08) |
| FY2023 | −2.39% | (8.27) |
| FY2022 | 5.88% | (2.87) |
| FY2021 | 8.75% | 7.83 |
| FY2020 | 0.92% | (4.28) |
| FY2019 | 5.20% | 0.50 |
| FY2018 | 4.70% | (1.44) |
| FY2017 | 6.14% | 6.14 |
| FY2016 | 0.00% | — |
Against its own ten years
Return on equity against peers
| Company | Return on equity |
|---|---|
| NVST Envista Holdings Corporation | 20.5% |
| MMSI Merit Medical Systems, Inc. compare | 9.78% |
| STVN Stevanato Group S.p.A. compare | 9.22% |
| ATRC AtriCure, Inc. compare | 2.95% |
| ICUI ICU Medical, Inc. compare | 2.79% |
| WRBY Warby Parker Inc. compare | 1.93% |
| MMED MiniMed Group, Inc. compare | 0.00% |
| TFX Teleflex Incorporated compare | −28.9% |
| PLSE Pulse Biosciences, Inc compare | −60.7% |
| Medical Instruments & Supplies industry median | 0.00% |
| Healthcare sector median | −26.3% |
| Market median | 0.51% |
What Return on equity is
ROE shows how much profit a company earns for its shareholders on the equity they have in the business.
Annual: Net Income Allotted to Shareholders ÷ Average Common Equity; TTM: Net Income Allotted to Shareholders ÷ Average Common Equity (latest quarter)
More on NVST
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement